Tuesday, January 28, 2025
Read the Digital Magazines Subscribe to the Magazines
Subscribe

Life Sciences

BridgeLabs-at-Pegasus-Park-Dallas
DevelopmentLife SciencesTexas

Partnership Completes 135,000 SF Life Sciences Project in Northwest Dallas

by Taylor Williams

DALLAS — A partnership between Montgomery Street Partners and J. Small Investments has completed Bridge Labs at Pegasus Park, a 135,000-square-foot life sciences development in northwest Dallas. The facility is part of Pegasus Park, which is a redevelopment of a 25-acre office campus that originally served as the home of Zale Corp., the parent company of jewelry retailer Zale. Campus amenities include a conference center, brewery, fitness center and outdoor dining and socialization spaces. Perkins + Will designed the project, and Swinerton served as the general contractor. JLL is the leasing agent for the broader campus, which the partnership owns in conjunction with Lyda Hill Philanthropies.

Continue Reading
FacebookTwitterLinkedinEmail
PACE Appeal Rafi Golberstein
Content PartnerData CentersFeaturesHospitalityLife SciencesLoansMidwestMultifamilyNortheastOfficeSelf-StorageSoutheastTexasWestern

C-PACE Maintains Appeal in Lower Interest Rate Environment

by Sarah Daniels

The Federal Reserve’s decision to begin aggressively hiking the federal funds rate in 2022 threw the commercial real estate market into turmoil. Property investors found it difficult to refinance much cheaper short-term loans that were often used to renovate or develop properties. However, the interest rate spike greatly enhanced the viability of commercial property assessed clean energy (C-PACE) financing, a type of loan that becomes an assessment that borrowers pay along with their tax bill. The program emerged more than a decade ago and generally pays for energy, water and seismic resiliency upgrades in new construction and rehabs, including retroactively. As a result, developers embraced C-PACE as they sought ways to pay down debt to secure new financing or loan extensions and modifications. Now that the Federal Reserve has reversed course with its 50-basis-point federal funds rate reduction in September — and with Wall Street anticipating additional rate cuts before the end of the year — will C-PACE demand start to cool? Don’t count on it, says Rafi Golberstein, founder and CEO of PACE Loan Group, a direct lender of C-PACE financing based in Minneapolis, Minn. From the competitive cost of capital to the continued restraints on bank lending, C-PACE …

Continue Reading
FacebookTwitterLinkedinEmail
LINX-Watertown
Life SciencesLoansMassachusettsNortheast

Clarion Partners Receives $94M Loan for Refinancing of Metro Boston Life Sciences Facility

by Taylor Williams

WATERTOWN, MASS. — New York-based Clarion Partners has received a $94 million loan for the refinancing of LINX, a 185,015-square-foot life sciences facility in the western Boston suburb of Watertown. Completed in 2018, the two-story facility was fully leased at the time of the loan closing to three tenants: C4 Therapeutics, Addgene and Tectonic Therapeutic. Amenities include a grab-and-go café, indoor bike storage space, a locker room with showers, green space, a bocce ball court and shuttle service to Harvard Square. Riaz Cassum, Amy Lousararian and Robyn King of JLL arranged the five-year loan through European lender Société Générale on behalf of Clarion Partners.

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesMassachusettsNortheast

JLL Negotiates 60,000 SF Life Sciences Lease in Malden, Massachusetts

by Taylor Williams

MALDEN, MASS. — JLL has negotiated a 60,000-square-foot life sciences lease in Malden, a northern suburb of Boston. The tenant, locally based battery maker Alsym Energy, is relocating its headquarters from nearby Woburn to Exchange 200, a 352,000-square-foot facility that is a redevelopment of a former office building. Molly Heath, Chris McCauley and Anslee Krouch of JLL represented the landlord, a joint venture between Boston-based Berkeley Investments and Chicago-based Singerman Real Estate, in the lease negotiations. Bill Lynch and Caroline Evans of Colliers represented the tenant, which will continue operations at its Woburn facility.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentHealthcareIndianaIndustrialLife SciencesMidwestTop Stories

Eli Lilly to Build $4.5B Center for Advanced Manufacturing, Drug Development in Lebanon, Indiana

by Kristin Harlow

LEBANON, IND. — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to invest $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development in Lebanon, about 27 miles northwest of Indianapolis. The Medicine Foundry, slated to open in late 2027, will be located in Indiana’s LEAP Research and Innovation District. The project brings Lilly’s total investment in the area to more than $13 billion. Earlier this year, Lilly released plans for a $5.3 billion expansion of its pharmaceutical manufacturing facility in Lebanon. “As we accelerate our work to discover new medicines for the toughest diseases, we’re continuing to invest in state-of-the-art infrastructure to support our growing pipeline,” says David Ricks, Lilly’s chair and CEO. “In addition to supplying high-quality medicine for our clinical studies, this new complex will further strengthen our process development and scale up our manufacturing capabilities to speed delivery of next-generation medicines to patients around the world.” Lilly says the flexible design of the new facility will enable production of various molecular therapies, including drug substances for small molecules, biologics and nucleic acid therapies. New technologies developed at the Medicine Foundry will be transferred to Lilly’s other manufacturing sites …

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesNortheastPennsylvania

KOKO Medical Signs 19,859 SF Life Sciences Lease in Exton, Pennsylvania

by Taylor Williams

EXTON, PA. — KOKO Medical has signed a 19,859-square-foot life sciences in Exton, a western suburb of Philadelphia. The medical device and women’s healthcare provider is relocating and expanding from nearby Malvern to the 63,000-square-foot building at 770 Pennsylvania Drive, which is part of the 800-acre Eagleview mixed-use development. Mitch Reading of Tactix Real Estate Advisors represented the tenant in the lease negotiations. Sam Sherrill represented the landlord, Hankin Group, on an internal basis.

Continue Reading
FacebookTwitterLinkedinEmail
AcquisitionsLife SciencesWashingtonWestern

Alexandria Real Estate Equities Sells Life Sciences Facility in Seattle to Fred Hutch Cancer Center for $150M

by Amy Works

SEATTLE — Alexandria Real Estate Equities, through an affiliate, has completed the sale of 1165 Eastlake Avenue East in Seattle’s Lake Union submarket to long-standing tenant Fred Hutch Cancer Center for $150 million. Alexandria developed and delivered the 100,086-square-foot, single-tenant, Class A life sciences building in 2021. Proceeds from the disposition of 1165 Eastlake will be reinvested into Alexandria’s leased development and redevelopment pipeline, which consists of research-and-development centers for top life sciences companies, including Bristol Myers Squibb and Novo Nordisk. As part of the transaction, Alexandria, through an affiliate, entered into a strategic joint venture partnership with Fred Hutch for nearby 1201 and 1208 Eastlake Avenue East, aggregating 206,031 rentable square feet, through a transfer of partial interests from the prior joint venture partner to Fred Hutch. Alexandria’s ownership interest in each 1201 and 1208 Eastlake remains unchanged at 30 percent. Fred Hutch executed early renewals at both properties, including a 15-year lease extension at 1201 Eastlake, where it occupies the entire building. These two life sciences facilities support the cancer center in its efforts to translate cancer and infectious disease discoveries into treatments and cures.

Continue Reading
FacebookTwitterLinkedinEmail
AcquisitionsLife SciencesTexas

Ascension Advisory Arranges Sale-Leaseback of 59,720 SF Life Sciences Facility in Webster, Texas

by Taylor Williams

WEBSTER, TEXAS — Ascension Advisory has arranged the sale-leaseback of a 59,720-square-foot life sciences facility in Webster, a southeastern suburb of Houston. The property was originally built in 1984. The acquisition of the facility comes as part of the buyer, mission-critical materials and chemicals manufacturer VION Biosciences, purchasing both the business operations and physical real estate of the tenant, Ansh Labs, including the Webster facility. The sales price and lease details were not disclosed.

Continue Reading
FacebookTwitterLinkedinEmail
44-Middlesex-Bedford-Massachusetts
DevelopmentIndustrialLife SciencesMassachusettsNortheast

Camber, Wheelock Complete 147,000 SF Industrial, Life Sciences Project in Bedford, Massachusetts

by Taylor Williams

BEDFORD, MASS. — A partnership between Boston-based Camber Development and Connecticut-based Wheelock Street Capital has completed a 147,000-square-foot industrial and life sciences project in Bedford, about 20 miles northwest of Boston. The project represents Phase I of a larger manufacturing campus known as 44 Middlesex, and the second phase will also center on the delivery of a 147,000-square-foot building. Construction of that facility is expected to begin in 2025 and to last about a year. Both buildings will be two-story structures and will have 105,000 square feet on the ground floor and a 42,000-square-foot mezzanine space on the second floor, as well as clear heights of 36 feet. Newmark is the leasing agent for the development.

Continue Reading
FacebookTwitterLinkedinEmail
Bedford-Labs
Life SciencesLoansMassachusettsNortheast

JLL Arranges $150M Loan for Refinancing of Metro Boston Life Sciences Facility

by Taylor Williams

BEDFORD, MASS. — JLL has arranged a $150 million loan for the refinancing of Bedford Labs, a 288,000-square-foot life sciences facility located about 20 miles northwest of Boston. Bedford Labs, which sits on a 52-acre site that can support up to 300,000 square feet of new construction, is a redevelopment of a former single-tenant office building. The facility includes a 28,000-square-foot amenity space and was fully leased to biotechnology firm Sarepta Therapeutics at the time of the loan closing. Brett Paulsrud, Tom Sullivan and Mike Shepard of JLL arranged the loan through an affiliate of Apollo Global Management. The borrower is a partnership between AEW Capital Management, Redgate and Optimum Asset Management.

Continue Reading
FacebookTwitterLinkedinEmail
Newer Posts
Older Posts